Evaluation of the hypochromic erythrocyte and reticulocyte hemoglobin content provided by the Sysmex XE-5000 analyzer in diagnosis of iron deficiency erythropoiesis

Mauro Buttarello 1 , Rachele Pajola 2 , Enrica Novello 3 , Giacomo Mezzapelle 4  and Mario Plebanihttp://orcid.org/0000-0002-0270-1711 5
  • 1 Clinical Pathology Laboratory, Hospital of Adria, Piazza degli Etruschi, 45011, Adria (RO), Italy
  • 2 Cinical Pathology Laboratory, Azienda ULSS 8 Castelfranco Veneto, Treviso, Italy
  • 3 Transfusion Center, Azienda ULSS 2 Feltre, Belluno, Italy
  • 4 Clinical Pathology Laboratory, Azienda ULSS 19 Adria, Rovigo, Italy
  • 5 Department of Laboratory Medicine, Azienda Ospedaliera-Università di Padova, Padova, Italy
Mauro Buttarello, Rachele Pajola, Enrica Novello, Giacomo Mezzapelle and Mario PlebaniORCID iD: http://orcid.org/0000-0002-0270-1711

Abstract

Background:

Iron deficiency represents the most frequent cause of anemia. To diagnose iron deficiency some biochemical tests such as serum ferritin and the transferring saturation percent (TSAT%) are usually used. Recently, some hematological parameters such as mean reticulocyte hemoglobin content (CHr or Ret-He) and percentage of hypochromic RBCs (Hypo% or %Hypo-He) were proposed as alternative to biochemical tests. In this study, the analytic performance and the diagnostic efficiency of these two parameters provided by Sysmex XE5000 analyzer on iron deficiency patients with or without anemia (IDA and ID, respectively) were evaluated.

Methods:

One hundred and sixty-four healthy adults, 58 with IDA, 21 with iron depleted stores (ID), 23 with β-thalassemia trait, and 24 with non iron deficiency anemia were selected. The gold standard used to define iron deficiency was the coexistence of serum ferritin below 15 μg/L (12 in women) and TSAT <16%.

Results:

For %Hypo-He, the best cut-off value for both IDA and ID is 0.9% while for Ret-He is 30.6 pg. For both parameters the performance was better to diagnose IDA (AUC, 0.96 and 0.98) than ID (AUC, 0.93 and 0.95). The Ret-He behavior was always slightly better than that of %Hypo-He.

Conclusions:

The use of these two parameters is useful to detect iron deficiency conditions if the hemoglobin synthesis has already been compromised.

  • 1.

    De Maeyer E, Adiels-Teyman M. The prevalence of anemia in the world. World Health Stat Q 1985;38:303–16.

  • 2.

    Cook JD, Skikne BS. Iron deficiency: definition and diagnosis. J Intern Med 1989;226:349–55.

  • 3.

    Thomas DW, Hinclhiffe RF, Briggs C, MC Dougall IC, Littlewood T, Cavill I. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol 2013;161:639–48.

  • 4.

    Finch CA, Bellotti V, Stray S, Lipschitz DA, Cook JD, Pippard MJ, et al. Plasma ferritin determination as a diagnostic tool. West J Med 1986;145:657–63.

  • 5.

    Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. J Am Med Assoc 1997;277:973–6.

  • 6.

    Locatelli F, Aljama P, Barany P, Canaud B, Carrera F, Eckardt KU, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 2004;19(suppl 2):ii1–ii47.

  • 7.

    KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006;47(suppl 3):s11–145.

  • 8.

    UK Renal Association. Clinical Practice Guidelines Module 2: complications. UK Renal Association 2007. Available at: www.renal.org/guidelines.

  • 9.

    Chung M, Chan JA, Moorthy D, Hadar N, Ratichek SJ, Concannon TW, et al. Biomarkers for assessing and managing iron deficiency anemia in late-stage chronic kidney disease: future research needs. Agency for Health Care research and quality. Rockville, MD: US Department of Health and Human Services, 2013.

  • 10.

    Brugnara C. A haematological “gold standard” for iron-deficient states (editorials)? Clin Chem 2002;48:981–2.

  • 11.

    MacDougall IC, Cavill I, Hulme B, Bain B, McGregor E, McKay P, et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. Br Med J 1992;304:225–6.

  • 12.

    NICE. Anaemia management in people with chronic kidney disease. Clinical guideline 114. London: National Institute for Health and Clinical Excellence, 2011.

  • 13.

    Tessitore N, Solero GP, Lippi G, Bassi A, Faccini GB, Bedogna V, et al. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant 2001;16:1416–23.

  • 14.

    Chuang CL, Liu RS, Wei YH, Huang TP, Tarng DC. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. Nephrol Dial Transplant 2003;18:370–7.

  • 15.

    Bovy C, Gothot A, Delanaye P, Warling X, Krzesinski JM, Beguin Y. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrol Dial Transplant 2007;22:1156–62.

  • 16.

    Buttarello M, Pajola R, Novello E, Rebeschini M, Cantaro S, Oliosi F, et al. Diagnosis of iron deficiency in patients undergoing hemodialysis. Am J Clin Pathol 2010;133:949–54.

  • 17.

    Franck S, Linssen J, Messinger M, Thomas L. Potential utility of Ret-Y in the diagnosis of iron- restricted erythropoiesis. Clin Chem 2004;50:1240–2.

  • 18.

    Clinical and Laboratory Standards Institute (CLSI). Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline-third edition. Wayne, PA: C28-A3, 2008.

  • 19.

    Camaschella C. Iron-deficiency anemia. N Engl J Med 2015;372:1832–43.

  • 20.

    Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 2006;107:1747–50.

  • 21.

    Fishbane S, Kowalsky EA, Imbriano LJ, Maesaka JK. The evaluation of iron status in hemodialysis patients. J Am Soc Nephrol 1996;7:2654–7.

  • 22.

    Urrechaga E, Borque L, Escanero JF. Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism. Clin Chem Lab Med 2009;47:1411–6.

  • 23.

    Urrechaga E, Borque L, Escanero JF. Erythrocyte and reticulocyte indices in the assessment of erythropoiesis activity and iron availability. Int J Lab Hem 2013;35:144–9.

  • 24.

    Noronha JF, Grotto HZ. Measurement of reticulocyte and red blood cell indices in patients with iron deficiency anemia and β-thalassemia. Clin Chem Lab Med 2005;43:195–7.

  • 25.

    Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002;48:1066–76.

  • 26.

    Katodritou E, Terpos E, Zervas K, Speletas M, Kapetanos D, Kartsios C, et al. Hypochromic erythrocytes(%): a reliable marker for recognozing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma. Ann Hematol 2007;86:369–76.

  • 27.

    Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret-He) and assessment of iron-deficient states. Clin Lab Haematol 2006;28:303–8.

  • 28.

    Garzia M, Di Mario A, Ferraro E, Tazza L, Rossi E, Luciani G, et al. Reticulocyte haemoglobin equivalent; an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy. Lab Hematol 2007;13:6–11.

  • 29.

    Maconi M, Cavalca L, Danise P, Cardarelli F, Brini M. Erythrocyte and reticulocyte indices in iron deficiency in chronic kidney disease: comparison of two methods. Scand J Clin Lab Invest 2009;69:365–70.

Purchase article
Get instant unlimited access to the article.
$42.00
Log in
Already have access? Please log in.


Journal + Issues

Clinical Chemistry and Laboratory Medicine ( CCLM) publishes articles on novel teaching and training methods applicable to laboratory medicine. CCLM welcomes contributions on the progress in fundamental and applied research and cutting-edge clinical laboratory medicine. It is one of the leading journals in the field, with an impact factor of over three. CCLM is the official journal of nine national clinical societies and associated with EFLM.

Search